antifibrotic

Pirfenidone Phase 3 Results Published Today in The Lancet
Yahoo/PR NewsWire
Sat, 05/14/11 - 12:48 pm
pirfenidone
anti-inflammatory
antifibrotic
idiopathic pulmonary fibrosis